Table 2.
Characteristics | Frequency |
---|---|
Mean age (years) | 51.16 |
Comorbidity | |
Diabetes mellitus | 10 (6.3%) |
Diabetes and hypertension | 10 (6.3%) |
Hypertension | 33 (20.6%) |
Hypothyroidism | 11 (6.9%) |
Others | 7 (4.4%) |
None | 89 (55.6%) |
Diagnosis | |
Carcinoma cervix (n = 74) | |
Squamous cell ca | 72 (97.3%) |
Adenocarcinoma | 2 (2.7%) |
Carcinoma endometrium (n = 17) | |
Endometrioid | 10 (58.8%) |
High-grade serous | 1 (5.9%) |
Carcinosarcoma | 6 (35.3%) |
Carcinoma ovary (n = 67) | |
High-grade serous | 53 (79.1%) |
Mucinous | 5 (7.5%) |
Low-grade serous | 3 (4.5%) |
Germ cell tumor | 5 (7.5%) |
Endometrioid | 1 (1.4%) |
Carcinoma vault (n = 2) | |
Squamous cell ca | 2 (100%) |
Stage | |
Carcinoma cervix | |
Early stage | 7 (9.5%) |
Locally advanced | 65 (87.8%) |
Distant metastasis | 2 (2.7%) |
Carcinoma endometrium | |
Early stage | 10 (58.9%) |
Locally advanced | 7 (41.1%) |
Carcinoma ovary | |
Early stage | 5 (7.5%) |
Locally advanced | 48 (71.6%) |
Distant metastasis | 14 (20.9%) |
Carcinoma vault | |
Stage II | 2 (100%) |
Number of visits | |
1 | 77 (48.1%) |
2 | 81 (50.6%) |
3 | 2 (1.3%) |